Vivos (RDGL) Other Non-Current Liabilities (2013 - 2024)
Vivos recorded quarterly Other Non-Current Liabilities of $40949.0 in Q4 2024, up 309.49% quarter-over-quarter from $10000.0 in Q3 2023.
Vivos' Other Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $40949.0 for Q4 2024.
- In Q4 2024, Other Non-Current Liabilities changed N/A year-over-year to $40949.0; the TTM figure through Dec 2024 stood at $40949.0 (changed N/A YoY), while the FY2024 annual figure was $40949.0, changed N/A from the prior year.
- Other Non-Current Liabilities came in at $40949.0 for Q4 2024 at Vivos, up from $10000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $40949.0 in Q4 2024 to a low of $10000.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 40,949.00 |
| Sep 30, 2023 | 10,000.00 |
| Dec 31, 2018 | 4.82 Mn |
| Dec 31, 2016 | 2.33 Mn |
| Jun 30, 2013 | 865,896.00 |